These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12043040)

  • 1. [Intensity of psychotic symptoms and selected demographic data as predictors of effectiveness of psychotherapy of schizophrenic patients in a day-hospital treatment].
    Kamiński R; Lisiecka A
    Psychiatr Pol; 2002; 36(2):211-23. PubMed ID: 12043040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Schizophrenic patients in ambulatory treatment of a psychiatric hospital and in general practice of established psychiatrists].
    Kaiser W; Isermann-Gerke M; Linden M; Wilms HU
    Nervenarzt; 1991 Mar; 62(3):158-64. PubMed ID: 1675771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the emotional blunting and its prognostic importance during neuroleptic treatment of schizophrenia].
    Kukulska D
    Psychiatr Pol; 2003; 37(6):999-1012. PubMed ID: 14727372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of Hunperdal Richter in psychiatry].
    Magyar GI; Fadgyas I
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):111-5. PubMed ID: 19827319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early intervention in increased risk for schizophrenic illnesses. Multimodal psychotherapy--antipsychotic drugs only in treatment failure].
    Wieneke A; Bechdolf A; Schultze-Lutter F
    MMW Fortschr Med; 2000 Mar; 142(10):30-2. PubMed ID: 10748600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additional therapeutic effect of group music therapy for schizophrenic patients: a randomized study.
    Ulrich G; Houtmans T; Gold C
    Acta Psychiatr Scand; 2007 Nov; 116(5):362-70. PubMed ID: 17919155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between patient characteristics and psychiatric day care outcomes in schizophrenic patients.
    Miyaji S; Yamamoto K; Morita N; Tsubouchi Y; Hoshino S; Yamamoto H; Sakai Y; Tanaka K; Miyaoka H
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):293-300. PubMed ID: 18588589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical treatment of schizophrenia today].
    Preissler HP
    Med Welt; 1981 Nov; 32(47):1793-8. PubMed ID: 6118807
    [No Abstract]   [Full Text] [Related]  

  • 14. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
    Salimi S; Fotouhi A; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Mohammadi MR; Noorbala AA; Ahmadi-Abhari SA; Hajiazim M; Abbasi SH; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):726-32. PubMed ID: 18096287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of inpatient psychiatric and psychotherapeutic treatment of patients with schizophrenia, schizoaffective and other psychotic disorders].
    Leichsenring F; Dumpelmann M; Berger J; Jager U; Rabung S
    Z Psychosom Med Psychother; 2005; 51(1):23-37. PubMed ID: 15834838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in defense mechanisms resulting from a Day Treatment Center therapy in persons suffering from psychotic disorders].
    Cichocki L
    Psychiatr Pol; 2008; 42(1):47-57. PubMed ID: 18567403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
    Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
    Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of untreated psychosis and it's effect on the functional outcome in schizophrenia - preliminary results.
    Sarotar BN; Pesek MB; Agius M; Pregelj P; Kocmur M
    Psychiatr Danub; 2008 Jun; 20(2):179-83. PubMed ID: 18587288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Self-efficacy and remission in schizophrenia].
    Tartas M
    Psychiatr Pol; 2002; 36(6 Suppl):249-55. PubMed ID: 12647446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.